Accredited Investors Employee Shareholders Institutions Private Companies Who We Serve Trading and InvestingData SolutionsPrivate Asset Custody Institutional TradingForge ProTrade private companies with Forge’s institutional brokerage toolBrowse CompaniesIndividual InvestingForge MarketsFind new private company investment opportunitiesForge DataAnalyze private markets via Forge’s intuitive web applicationForge Private Market IndexMonitor a benchmark for actively traded private companies Forge Accuidity Private Market IndexInvest in an institutionally-managed diversified basket of private companies (QPs only)Self-Directed IRAForge TrustInvest in private companies and other alternative assets through a tax-advantaged Self-Directed IRASolutions All InsightsPrivate Market ReportsMarket InsightsBuying and Selling Pre-IPO All ReportsPrivate Market Updates Forge Investment OutlookStartup News and TrendsPrivate Market Data and AnalyticsTech IPO Calendar for 2024Private Market ExplainedBuying Pre-IPO SharesSelling Pre-IPO Shares Glossary Videos FAQsInsights About Us Leadership Investor Relations People & Culture Careers About

Passage Bio Stock

Q: How to sell Passage Bio stock?

If you hold private company shares of Passage Bio - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Passage Bio stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

passagebio.comHealthcare / BioTech & PharmaFounded: 2018Funding to Date: $225.5MM

Passage Bio is a genetic medicines company focused on developing a deep pipeline of adeno-associated virus (AAV) delivered therapeutics for the treatment of rare monogenic central nervous system disorders (CNS).

Buy or sell Passage Bio stockLearn more about Passage Bio IPO

OverviewFinancingsValuation

Enterprise Value

Access Passage Bio’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Passage Bio.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.

Access Stock Price

Animation displayed is not current and securities are shown for illustrative purposes only.

Team

Management Team

Jill Quigley JD

Chief Operating Officer, Operations

Gary Romano Ph.D

Chief Medical Officer

Tadataka Yamada MD

Co-Founder & Chairman

Richard Morris

Chief Financial Officer, Finance

James Wilson Ph.D

Co-Founder & Chief Scientific Advisor

Bruce Goldsmith Ph.D

Chief Executive Officer & Board Member

Alex Fotopoulos

Chief Technology Officer, Technology

Stephen Squinto Ph.D

Co-Founder, Board Member & Acting Head of R&D

Board Members

Bruce Goldsmith Ph.D

Sandip Kapadia

Thomas Woiwode Ph.D

Versant Venture Management

Liam Ratcliffe Ph.D

Stephen Squinto Ph.D

Patrick Heron

Frazier Healthcare Partners

Saqib Islam JD

Tadataka Yamada MD

Passage Bio stock FAQs

Can you buy Passage Bio stock?

As Passage Bio is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company like Passage Bio, you must be an accredited investor. If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Passage Bio stock?

To invest in a private company like Passage Bio through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process.)

Create a free account to access Forge’s marketplace.
Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies.
Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Passage Bio stock?

Yes, you may be able to sell your Passage Bio stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company's interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Passage Bio stock?

If you hold private company shares of - whether as an employee or an early investor - Forge can help you sell them.

Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have.
Indicate your interest to sell your Passage Bio stock on our platform.
Work with your dedicated Private Market Specialist who'll help guide you through every step of the transaction.

Is Passage Bio a public company?

No, Passage Bio is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Passage Bio’s stock price?

Passage Bio is a privately held company and therefore does not have a public stock price. However, you may access Passage Bio’s private market stock price with Forge Data.

What is Passage Bio’s stock ticker symbol?

Passage Bio does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Genomeweb 05/03/2021

InformedDNA Partners With Gene Therapy Firm Passage Bio on Dementia Genetic Testing

Xconomy 02/28/2020

Xconomy: Passage Bio's IPO Raises $216M to Fund Gene Therapy Studies

Gene therapy developer Passage Bio priced its initial public offering at $18 per share, raising $216 million---72 percent more than it originally planned

Xconomy 02/14/2019

Xconomy: Passage Bio Gets $116M As Wilson, Yamada Team Up On Gene Therapy Again

Longtime biopharmaceutical executive Tachi Yamada helped keep the work of gene therapy pioneer James Wilson alive 20 years ago when Wilson was mired in

Browse More Insights

Frequently Asked Questions

Updated on: Jul 26, 2024

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.